TORONTO , May 14, 2021 /CNW/ - Peter Rands , Chief Executive Officer, Small Pharma Inc. ("Small Pharma" or "the Company") (TSXV: DMT), and his team joined Dani Lipkin , Director, Global Business Development TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and open the market.
Small Pharma is a neuropharmaceutical company specialised in IP led development of novel treatments for mental health conditions, with a focus on depression. Small Pharma initiated a clinical program into DMT assisted therapy in February 2021 . This program includes a Phase I/IIa trial on their lead candidate alongside development of a robust pipeline of proprietary preclinical assets. For more information visit https://www.smallpharma.co.uk/ .
For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact avservices@tmx.com . The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET
Date: Friday, May 14 , 2021
Time: 9:00am - 9:30am
Place: Virtually Broadcast
SOURCE TSX Venture Exchange
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/14/c8312.html